Oxygen-controlled automated neural differentiation of mouse embryonic stem cells

In this research article, published in Regenerative Medicine, learn more about an automation platform capable of maintaining oxygen tension control during both the cell-culture and liquid-handling. This article has been made free exclusively for members of RegMedNet.

Go to the profile of Regenerative Medicine
Aug 08, 2019

Embryonic stem cells are showing promise as a therapeutic avenue for a number of conditions, but widespread application of the technology will rely on robust, reproducible and high-yield product methods. Automation and oxygen tension control are two tools that provide significant improvements to the reproducibility and efficiency of stem cell production processes. 

In this research article, from an international team at The Advanced Centre for Biochemical Engineering, University College London (London, UK), and Biomedical Research Division, Centro Medico Nacional ‘20 de Noviembre’ – ISSSTE (Mexico City, Mexico), learn more about the development of an automated platform for maintaining oxygen tension control for 2D embryonic cell culture and differentiation. Use of the platform at the cell culture and liquid handling stages results in improvements in the differentiation efficiency.

Read the research article, free exclusively for RegMedNet members>>

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.